AI assistant
BIO-GENE TECHNOLOGY LTD — Director's Dealing 2023
Jul 25, 2023
64521_rns_2023-07-25_54c06f12-77b3-41ab-8037-3c68cc702a8b.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
Name of entity: - Bio-Gene Technology Limited
ABN: – 32 071 735 950
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Peter May |
|---|---|
| Date of last notice | 5 August 2022 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
==> picture [433 x 322] intentionally omitted <==
----- Start of picture text -----
Direct or indirect interest Direct
Nature of indirect interest Peter Donald and Sondra May atf May
(including registered holder) Superannuation Fund. 407,129 ordinary shares
Note: Provide details of the circumstances giving rise to the relevant
interest.
The Director is a member of the Superannuation
Fund
Date of change 27 July 2023
No. of securities held prior to change Direct: 1,537,402 ordinary shares
Indirect: 407,129 ordinary shares
Class Ordinary shares
Number acquired N/A
Number disposed 162,326
Value/Consideration Nil
Note: If consideration is non-cash, provide details and estimated valuation
No. of securities held after change Direct: 1,375,076 ordinary shares
Indirect: 407,129 ordinary shares
Nature of change Cancellation of shares in accordance with the rules
Example: on-market trade, off-market trade, exercise of options, issue of of the Loan Share Plan
securities under dividend reinvestment plan, participation in buy-back
----- End of picture text -----
- See chapter 19 for defined terms.
11/3/2002
Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
Part 2 – Change of director’s interests in contracts N/A
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change
Part 3 –[+] Closed period
| Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required? |
No |
|---|---|
| If so, was prior written clearance provided to allow the trade to proceed during this period? |
|
| If prior written clearance was provided, on what date was this provided? |
==> picture [116 x 60] intentionally omitted <==
Rod Valencia Company Secretary 26 July 2023
- See chapter 19 for defined terms.
Appendix 3Y Page 2
11/3/2002